Burosumab treatment in a child with cutaneous skeletal hypophosphatemia syndrome: A case report

Cutaneous skeletal hypophosphatemia syndrome (CSHS) is a rare disorder caused by somatic mosaicism for the gain of function RAS mutations . Affected patients have segmental epidermal nevi, dysplastic cortical bony lesions, and fibroblast growth factor-23 (FGF23)–mediated hypophosphatemic rickets. He...

Descripción completa

Detalles Bibliográficos
Autores principales: Khadora, Manal, Mughal, M. Zulf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502709/
https://www.ncbi.nlm.nih.gov/pubmed/34660853
http://dx.doi.org/10.1016/j.bonr.2021.101138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502709/
https://www.ncbi.nlm.nih.gov/pubmed/34660853
http://dx.doi.org/10.1016/j.bonr.2021.101138

Ejemplares similares